IBB (Nasdaq Biotechnology) Stock Analysis - SEC Filings

Nasdaq Biotechnology (IBB) is a publicly traded the market company. As of May 20, 2026, IBB trades at $167.11 with a market cap of $0 and a P/E ratio of 0.00. IBB moved +2.20% today. Year to date, IBB is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IBB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find IBB SEC filings?

Rallies organizes IBB SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

IBB Key Metrics

Key financial metrics for IBB
MetricValue
Price$167.11
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume1.77M
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest IBB News

IBB Analyst Consensus

IBB analyst coverage data. Average price target: $0.00.

Common questions about IBB

Where can I find IBB SEC filings?
Rallies organizes IBB SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show IBB 10-K and 10-Q filings?
Rallies organizes IBB SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is IBB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IBB. It does not provide personalized investment advice.
IBB

Nasdaq Biotechnology